期刊文献+

MRI延迟强化在肥厚型心肌病中的临床意义 被引量:14

Late gadolinium enhancement MRI in patients with hypertrophic cardiomyopathy
原文传递
导出
摘要 目的回顾性分析肥厚型心肌病(HCM)左心室心肌肥厚MRI延迟强化与临床特征的关系。方法收集79例HCM患者行MR检查,先常规实施心脏结构和功能检查,再进行钆对比剂延迟强化(LGE)扫描。按17节段法,分别测量心肌厚度、射血分数、左心室舒张期末容积等,并进行LGE评分。性别、胸闷等组间LGE的差异采用卡方检验,临床特征与测得数据采用Logistic回归分析,并以分析出阳性症状为参考标准评价LGE预测心脏事件的准确性,比较ROC曲线下面积。结果79例患者共计1343节段,其中肥厚节段633个,基底段前室间隔(第2节段)肥厚节段数最多(64个),其次为第9、3和8节段,分别为58、57和57个。LGE显示受累节段433个,第2节段最多(51个),其次为第8、9和14节段,分别为39、37和36个。左心房前后直径、LGE是心房颤动的独立预测因子(HR分别为1.11和1.12,P≤0.01),ROC曲线下面积分别为0.726、0.743;LGE是非持续性室性心律失常(NSVT)的独立预测因子(HR=1.15,P≤0.01),ROC曲线下面积为0.817。结论HCM患者心肌肥厚及LGE呈不对称性分布,LGE是HCM发生NSVT及心房颤动的独立危险因素。 Objective To retrospectively analyze the correlation of late gadolinium enhancement (LGE) on MRI with the extent of hypertrophic left ventricular myocardium and clinical features in hypertrophic eardiomyopathy. Methods Seventy-nine patients with hypertrophic cardiomyopathy were included in this study. Routine and functional cardiac MRI scans were performed, and then all patients underwent late gadolinium enhancement ( LGE ) MRI. The thickness of myocardium, ventricular function including ejection fraction (EF) and left ventricular end diastolic volume (LVEDV) according to the traditional 17-sectional method were measured and the LGE score was calculated. The Chi-square test and Logistic regression analysis were used to assess the accuracy of LGE predicting cardiac events and the area under ROC curve was compared. Results A total of 1343 segments including 633 hypertrophic segments in 79 patients were enrolled for the analysis. The basal anlerior ventricular septum was the most commonly involved hypertrophic segment ( n = 64 ) , following by the 9,3,8 segments ( n = 58,57,57, respectively). LGE was shown in 433 segments, while the basal anterior ventricular septurn was the most commonly involved segment ( n = 51 ), following by the 8,9,14 segments ( n = 39,37,36, respectively). The (a-p) diameter of the left atrium and LGE were the independent predictors of atrial fibrillation ( HR = 1.14,1.20, respectively, P≤0. 01 ) , and the area under ROC (AUC) was 0. 726 and 0. 743, respectively. LGE extent of the leftventricle was the independent predictor of NSVT (HR = 1.15, P ≤ 0.01 ), and the AUC was 0. 817. Conclusion The hypertrophic segments and LGE were asymmetric distributed, and the extent of LGE is an independent risk factor for the NSVT and atrial fibrillation.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2013年第5期396-400,共5页 Chinese Journal of Radiology
基金 首都医学发展科研基金联合攻关资助项目(2009-1004) 北京市科委首都临床特色应用研究资助项目(Z121107001012114)
关键词 肥厚型心肌病 心律失常 磁共振成像 Hypertrophic cardioinyopathy Arrhythmia Magnetic resonance imaging
  • 相关文献

参考文献12

  • 1Elliott P,McKenna WJ. Hypertrophic cardiomyopathy. Lancet,2004,363:1881-1891.
  • 2Salerno M, Kramer CM. Prognosis in hypertrophic cardiomyopathywith contrast-enhanced cardiac magnetic resonance : the futurelooks bright. J Am Coll Cardiol,2010,56: 888-889.
  • 3Cerqueira MD, Weissman NJ,Dilsizian V,et al. Standardizedmyocardial segmentation and nomenclature for tomographic imagingof the heart : a statement for healthcare professionals from theCardiac Imaging Committee of the Council on Clinical Cardiologyof the American Heart Association. Circulation, 2002, 105 :539-542.
  • 4Gersh BJ’Maron BJ,Bonow RO et al. 2011 ACCF/AHA Guidelinefor the Diagnosis and Treatment of Hypertrophic Cardiomyopathy :a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines :developed in collaboration with the American Association forThoracic Surgery, American Society of Echocardiography, AmericanSociety of Nuclear Cardiology,Heart Failure Society of America,Heart Rhythm Society, Society for Cardiovascular Angiography andInterventions,and Society of Thoracic Surgeons. J Am CollCardiol,2011,58: e212-e260.
  • 5Moon JC,McKenna WJ,McCrohon JA,et al. Toward clinical riskassessment in hypertrophic cardiomyopathy with gadoliniumcardiovascular magnetic resonance. J Am Coll Cardiol, 2003 ,41 :1561-1567.
  • 6Maron MS, Maron BJ, Harrigan C, et al. Hypertrophiccardiomyopathy phenotype revisited after 50 years withcardiovascular magnetic resonance. J Am Coll Cardiol,2009,54 ??220-228.
  • 70'Hanlon R,Grasso A, Roughton M, et al. Prognostic significanceof myocardial fibrosis in hypertrophic cardiomyopathy. J Am CollCardiol,2010,56: 867-874.
  • 8Maron BJ,Olivotto I,Spirito P,et al. Epidemiology of hypertrophiccardiomyopathy-related death : revisited in a large non-referral-based patient population. Circulation,2000,102 : 858-864.
  • 9汪晶,孔祥泉,徐海波,周国锋,刘芳,石浩军,刘定西.肥厚型心肌病延迟增强磁共振成像与心律失常的相关性[J].中华心血管病杂志,2010,38(9):775-780. 被引量:13
  • 10Papavassiliu T,Germans T, Fliichter S, et al. CMR finding inpatients with hypertrophic cardiomyopathy and atrial fibrillation. JCardiovasc Magn Reson ,2009 ,11 : 34-42.

二级参考文献24

  • 1张寄南,曹克将.肥厚型心肌病诊断与治疗——美国心脏病学学会/欧洲心脏病学学会、美国心脏病协会专家共识导读[J].中华心血管病杂志,2005,33(6):491-494. 被引量:35
  • 2Oka K,Tsujiuo T,Nakao S,et al.Symptomatic ventricular tachyarrhythmia is associated with delayed gadolinium enhancement in cardiac magnetic resonance imaging and with elevated plasma brain natriuretic peptide level in hypertrophic cardiomyopathy.J Cardiol,2008,52:146-153.
  • 3Maron BJ,Shen WK,Link MS,et al.Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.N Engl J Med,2000,342: 365 -373.
  • 4Maron BJ.Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.Eur Heart J,2000,21:1979-1983.
  • 5Vamava AM,Elliott PM,Mahon N,et al.Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy.Am J Cardiol,2001,88:275-279.
  • 6Basso C,Thiene G,Corrado D,et al.Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.Hum Pathol,2000,31:988-998.
  • 7Maron B J,Olivotto I,Spirito P,et al.Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referralbased patient population.Circulation,2000,102: 858-864.
  • 8Suk T,Edwards C,Hart H,et al.Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients.Heart Lung Circ ,2008,17:370-374.
  • 9Adabag AS,Maron BJ,Appelbaum E,et al.Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.J Am Coll Cardiol ,2008,51:1369-1374.
  • 10Matoh F,Satoh H,Shiraki K,et al.Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.J Card Fail,2007,13:372-379.

共引文献12

同被引文献77

  • 1赵世华.磁共振应作为无创评估心脏结构和功能的金标准——2010年心血管磁共振专家共识解读[J].中国循环杂志,2012,27(S01):90-92. 被引量:14
  • 2心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:547
  • 3岳云龙,韩鸿宾.真实稳态自由进动序列成像技术的原理及应用[J].中华放射学杂志,2007,41(6):659-662. 被引量:16
  • 4Skyschally A, Walter B, Heusch G. Coronary microembolization during early reperfusion: infarct extension, but protection by is- ehaemie posteonditioning[J]. Eur Heart J, 2013,34 (42) : 3314 - 3321.
  • 5Stenberg T A,Steigen T,Myrmel T. Microvaseular occlusions and coronary microembolization[J]. Stand Cardiovase J, 2011,45 (5) : 258-260.
  • 6Bekkers S C, Yazdani S K, Virmani R, et al. Mierovaseular ob- struetion:underlying patbophysiology and clinical diagnosis[J]. J Am Coll Cardiol,2010,55(16) :1649-1660.
  • 7Orn S, Manhenke C, Greve O J, et al. Microvaseular obstruction is a major determinant of infarct healing and subsequent left ventric- ular remodelling following primary pereutaneous coronary inter- vention[J]. Eur Heart J, 2009,30 (16) .. 1978- 1985.
  • 8Carlsson M, Wilson M, Martin A J, et al. Myocardial microinfare- tion after coronary mieroembolization in swine:MR imaging char- acterization[J]. Radiology, 2009,250(3) : 703-713.
  • 9Saeed M, Hetts S W, Ursell P C, et al. Evaluation of the acute effects of distal coronary microembolization using muhidetectorcomputed tomography and magnetic resonance imaging[J]. Magn Reson Med,2012,67(6) :1747-1757.
  • 10Wang J, Li L, Su Q, et al. The involvement of phosphatase and tensin homolog deleted on chromosome ten (PTEN) in the regu- lation of inflammation following coronary microembolization[J]. Cell Physiol Biochem,2014,33(6) :1963-1974.

引证文献14

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部